MedPage Today) — CHICAGO — An investigational viral immunotherapy (CAN-2409; aglatimagene besadenovec) combined with a prodrug improved disease-free survival (DFS) when added to standard curative-intent radiotherapy for newly diagnosed localized…
Viral Immunotherapy Reduces Recurrences in Early Prostate Cancer

Leave a Comment Leave a Comment